A Phase II Study of Carfilzomib in the Treatment of Relapsed/Refractory Mantle Cell Lymphoma

Summary

The goal of this clinical research study is to learn if carfilzomib can help control relapsed or refractory MCL. The safety of this drug will also be studied.

Timeline

Start

2014-07-14

Primary completion

2017-12-20

Completion

2017-12-20

Outcome

Outcome not reported

Stopped (Enrollment): “Terminated due to poor accrual”

Drugs

Indications